Cerebellar Dysfunction in Multiple Sclerosis
暂无分享,去创建一个
[1] N. Scolding,et al. Oxidative injury in multiple sclerosis cerebellar grey matter , 2016, Brain Research.
[2] M. Hallett. Isoniazid and action tremor in multiple sclerosis. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[3] J. Lechner-Scott,et al. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study , 2017, The Lancet Neurology.
[4] J. De Keyser,et al. Tremor in multiple sclerosis , 2007, Journal of Neurology.
[5] M. Deloire,et al. Cerebellar Assessment in Early Multiple Sclerosis , 2016, The Cerebellum.
[6] AJ Thompson,et al. A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis , 2011, Multiple sclerosis.
[7] S. Aksoy,et al. Effects of different exercise modalities on ataxia in multiple sclerosis patients: a randomized controlled study , 2017, Disability and rehabilitation.
[8] J. Zajicek,et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis ( CAMS study ) : multicentre randomised placebo-controlled trial , 2022 .
[9] P. Feys,et al. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis , 2009, Multiple sclerosis.
[10] D. Francis,et al. The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[11] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. , 1991, Brain : a journal of neurology.
[12] J. Lechner-Scott,et al. Risk of relapse phenotype recurrence in multiple sclerosis , 2014, Multiple sclerosis.
[13] Marco Bozzali,et al. Multiple sclerosis: white and gray matter damage associated with balance deficit detected at static posturography. , 2013, Radiology.
[14] T. R. K. Varma,et al. Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation? , 2007, British journal of neurosurgery.
[15] J. Volkmann,et al. [Deep brain stimulation for tremor in multiple sclerosis : consensus recommendations of the German Deep Brain Stimulation Association]. , 2009, Der Nervenarzt.
[16] E. Gray,et al. Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum. , 2012, Brain : a journal of neurology.
[17] P. Bain,et al. A study of tremor in multiple sclerosis. , 2001, Brain : a journal of neurology.
[18] S. Reingold,et al. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.
[19] A. Quattrone,et al. Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report , 2011, Journal of Neurology.
[20] R. Foster,et al. Reorganization of the axon membrane in demyelinated peripheral nerve fibers: morphological evidence. , 1980, Science.
[21] Rana Karabudak,et al. Physiotherapy Approaches in the Treatment of Ataxic Multiple Sclerosis: A Pilot Study , 2001, Neurorehabilitation and neural repair.
[22] S. Dib-Hajj,et al. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis , 2012, Annals of neurology.
[23] Pierre Grammond,et al. Contribution of different relapse phenotypes to disability in multiple sclerosis , 2017, Multiple sclerosis.
[24] M. Benedetti,et al. A task-oriented circuit training in multiple sclerosis: a feasibility study , 2014, BMC Neurology.
[25] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[26] W. Mcdonald,et al. The pathophysiology of multiple sclerosis , 2006 .
[27] J Zajicek,et al. The effect of cannabis on tremor in patients with multiple sclerosis , 2004, Neurology.
[28] L. Kappos,et al. Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis , 2014, PloS one.
[29] B. Scheithauer,et al. Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.
[30] P. Bossuyt,et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. , 2000, The New England journal of medicine.
[31] G. Beebe,et al. Studies on the natural history of multiple sclerosis. V. Long-term survival in young men. , 1970, Archives of neurology.
[32] D. Wraith,et al. Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells , 2011, Neuropathology and applied neurobiology.
[33] D. Altmann,et al. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction , 2009, Multiple sclerosis.
[34] Chiara Romualdi,et al. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[35] S. Waxman,et al. Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination , 2010, Journal of neuropathology and experimental neurology.
[36] F. Jacques. Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.
[37] S. Waxman. Demyelinating diseases--new pathological insights, new therapeutic targets. , 1998, The New England journal of medicine.
[38] W. Fogel,et al. Tiefe Hirnstimulation bei Multiple-Sklerose-Tremor , 2009, Der Nervenarzt.
[39] Hans Lassmann,et al. Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.
[40] N. Scolding,et al. Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum , 2014, Brain pathology.
[41] A. Lo,et al. Annexin II/p11 is up-regulated in Purkinje cells in EAE and MS , 2003, Neuroreport.
[42] M. Espir,et al. Paroxysmal symptoms as the first manifestations of multiple sclerosis. , 1980, Journal of neurology, neurosurgery, and psychiatry.
[43] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.
[44] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[45] D. Centonze,et al. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis , 2012, Neurobiology of Disease.
[46] M. Hallett,et al. Treatment of action tremor in multiple sclerosis with isoniazid , 1982, Neurology.
[47] P. Eldridge,et al. Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis–associated tremor , 2013, Acta Neurochirurgica.
[48] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[49] David H. Miller,et al. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.
[50] E. Aronica,et al. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis , 2008, Neuropharmacology.
[51] Stefanie Kuerten,et al. MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum , 2007, Journal of Neuroimmunology.
[52] J. Matsumoto,et al. Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study , 2012, European journal of neurology.
[53] Vladimir Fonov,et al. Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis , 2016, Multiple sclerosis.
[54] Massimo Filippi,et al. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis , 2017, Multiple sclerosis.
[55] E. Mowry,et al. The onset location of multiple sclerosis predicts the location of subsequent relapses , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[56] Marco Molinari,et al. The cerebellar cognitive profile. , 2011, Brain : a journal of neurology.
[57] S. Waxman,et al. Expression of Nav1.8 sodium channels perturbs the firing patterns of cerebellar purkinje cells , 2003, Brain Research.
[58] M. Filippi,et al. Relationship between damage to the cerebellar peduncles and clinical disability in multiple sclerosis. , 2014, Radiology.
[59] R. Swingler,et al. The morbidity of multiple sclerosis. , 1992, The Quarterly journal of medicine.
[60] N. Scolding,et al. Cell fusion in the brain: two cells forward, one cell back , 2014, Acta Neuropathologica.
[61] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[62] J Newcombe,et al. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[63] Y. Blanco,et al. Midbrain lesions and paroxysmal dysarthria in multiple sclerosis , 2008, Multiple sclerosis.
[64] P. Duquette,et al. Isoniazid for tremor in multiple sclerosis , 1985, Neurology.
[65] A. Coles,et al. Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients , 2016, Journal of the Neurological Sciences.
[66] D. Wade,et al. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients , 2004, Multiple sclerosis.
[67] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[68] W. Koller. Pharmacologic trials in the treatment of cerebellar tremor. , 1984, Archives of neurology.
[69] Arthur W. Toga,et al. Purkinje cell loss in experimental autoimmune encephalomyelitis , 2009, NeuroImage.
[70] A. Pauli,et al. The effect of core stability training on balance and mobility in ambulant individuals with multiple sclerosis: A multi-centre series of single case studies , 2010, Multiple sclerosis.
[71] Moses Rodriguez,et al. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population , 2004, Movement disorders : official journal of the Movement Disorder Society.
[72] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. , 1991, Brain : a journal of neurology.
[73] B. Weinshenker,et al. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis , 2015, Neurology.
[74] C. Young,et al. Treatment for ataxia in multiple sclerosis. , 2007, The Cochrane database of systematic reviews.